Form 8-K - Current report:
SEC Accession No. 0001564590-21-045076
Filing Date
2021-08-19
Accepted
2021-08-19 07:15:30
Documents
3
Period of Report
2021-08-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ck1783328-8k_20210819.htm 8-K 30856
2 EX-99.1 ck1783328-ex991_6.htm EX-99.1 221530
3 GRAPHIC gpdcevn0qne4000001.jpg GRAPHIC 9092
  Complete submission text file 0001564590-21-045076.txt   266167
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 211188388
SIC: 2836 Biological Products, (No Diagnostic Substances)